What if aging wasn’t an inevitable decline, but a pattern we could read, interpret, and influence? Dr. Natalia Trpchevska, longevity specialist at Switzerland’s AYUN Clinic, believes the key to aging well isn’t found in miracle cures or futuristic therapies, but in understanding how our bodies speak to us – long before disease appears. With a background in rigorous research at Karolinska Institutet and real-world clinical work, she builds a bridge between complex science and practical health strategies. In this conversation, she shares how personalized biomarkers, genetic insights, and systems-level thinking are shaping the future of prevention – and why adaptability, not youth, may become the new gold standard of exceptional health.
What originally sparked your interest in longevity and the science of aging?
“What really drew me in is the fact that so much of aging is preventable if you know what to look for. That’s where longevity medicine clicked for me, it’s about understanding patterns early and learning how to shift them. Longevity felt like a natural extension of my curiosity about how the human body works, and how we can support its own biological intelligence instead of working against it.”
Dr. Trpchevska’s path began in genetics, drawn by a fascination with how the body operates as an interconnected system. She saw genetics as a foundation, a blueprint where even the smallest variations could lead to vastly different health outcomes. As she delved deeper into age-related diseases, both in research and clinical work, it became clear that aging isn’t random. It’s driven by subtle, progressive changes that often start decades before symptoms appear.
Her scientific mindset was sharpened at the Karolinska Institutet, where she learned to think rigorously and question everything. Today, at AYUN, she applies that same depth to real-world care. “We take deep scientific insights and make them practical and personal” she explains – translating data into strategies that help patients shape the next decades of their lives.
AYUN Clinic, Switzerland
AYUN is Switzerland’s first walk-in longevity clinic – what makes this model powerful, and what stands in its way?
“We’ve removed the barriers – no long referral pathways, no specialist silos. People can come in out of curiosity and leave with deep insight into their biology. That accessibility is powerful, especially in a field that’s often seen as exclusive or only for the sick or elite.”
For Dr. Trpchevska, AYUN’s strength lies in making science accessible without losing depth. But true impact requires more than convenience – it calls for a mindset shift. “A check-up like this isn’t a wellness luxury – it’s a proactive investment in your future” she says. Reframing prevention as a necessity, not a privilege, remains one of the biggest challenges the field faces.
That rethinking must extend beyond individual clinics. In her view, longevity care needs a structural evolution – from fragmentation to integration. Today, healthcare still operates in disconnected parts: one doctor for the heart, another for hormones, a third for fatigue. But aging doesn’t work like that. “It’s systemic” she explains. That’s why, at AYUN, multidisciplinary teams collaborate in real time – physicians, geneticists, nutritionists, physiologists – all aligned around one shared goal: long-term, resilient health. Her hope is that this model won’t remain a rarity, but become the new standard.
AYUN Clinic, Switzerland
If she could design one gold-standard test, Dr. Trpchevska would merge genetics with real-time functional markers – CGM for metabolic flexibility, HRV for stress resilience, VO₂max and inflammatory markers.
“Genetics tells us your blueprint – how your body is designed to function – but those other markers show how well you’re adapting, recovering, and responding to life right now.”
It’s the interplay that matters: genetics for the long view, and functional markers for the present moment. That’s how we move from static diagnostics to adaptive health management – “which is where I think prevention really becomes powerful.”
AYUN Clinic, Switzerland
What still needs to happen before genetic testing can become a routine part of preventive care?
“The science is ready. What’s missing is a more integrated system.” According to the expert, we already have the tools to identify key gene variants related to inflammation, detoxification, hormone metabolism, nutrient processing or how someone might respond to fasting or medication. But implementation is lagging.
“We need better clinical frameworks that make genetic insights usable in everyday care – not just in research or niche settings.”
– she explains.
“What’s holding us back is more systemic than scientific,” she adds. The infrastructure simply isn’t there yet. Most healthcare providers aren’t trained to interpret genetic data meaningfully, and there are few clinical pathways to translate findings into tailored protocols. For now, this type of care lives mostly in specialized clinics like AYUN, where genomics already informs personalized plans for nutrition, hormone support, and risk prevention. “The future is here, it’s just unevenly distributed. Now it’s about scaling it responsibly.”
AYUN Clinic, Switzerland
Translating genetic data into tailored protocols also relies on the growing field of computational genomics. Currently, it’s most useful for risk stratification – helping identify how someone processes hormones, detoxifies, or responds to inflammation and stress. “It gives us a better starting point for personalization,” Dr. Trpchevska explains. But the real leap is still ahead. In the next five years, she expects genomics to move from descriptive to prescriptive: guiding not just what to address, but how, when, and in what dose.
Combined with AI and continuous data tracking, this could enable real-time, adaptive health strategies – where protocols evolve with each person’s biology and environment.
But even the most advanced genetic models need to be grounded in what the body is doing in real time. That’s where biomarkers come in – not just to signal disease, but to reflect how well the body is actually functioning. “The most powerful biomarkers are the ones that give us insight into the functional state of the body,” she says. Among them, she highlights VO₂max as a surprisingly strong predictor of longevity, along with fasting insulin, glucose variability, and inflammatory markers like hsCRP or IL-6. When viewed together, these data points reveal how the body adapts to stress – metabolically, hormonally, and at the cellular level – offering concrete levers for change.
AYUN Clinic, Switzerland
If longer life becomes the norm, she believes the real measure of health will be adaptability – the ability to recover, refocus, and stay resilient in the face of daily demands. “Exceptional health won’t just be about the absence of disease. It will be about functional capacity, mental clarity, and being fully engaged with life – even at 80.” And that, she says, starts long before any diagnosis.
“Your body is always communicating with you – and the earlier you learn to listen, the more power you have to shape your future health.”
For her, longevity isn’t about chasing perfection or reversing time, but about awareness and agency – making small, intelligent choices before things go wrong. “That’s where real change begins.”
This article contains product placement.
Author: Révész Bogi
(Featured image: Dr. Natalia Trpchevska)
